Objective
ESCAPE will rethink current practice for treating multimorbidity in elderly patients and break down health care silos that impede integrated care and lead to adverse outcomes. We will coordinate and optimise care, prioritising integration of treatment for mental distress and disorders in the treatment of multimorbidity. Our interdisciplinary multinational consortium of experts from general and hospital medical practice and psychology, health economics, ICT development and social innovation as well as patient and informal carer representatives, will develop a holistic, patient-centred intervention based on the blended collaborative care (BCC) approach and enhanced by cutting-edge information and communication technologies. Trained Care Managers will work closely together with the patient’s general practitioner under supervision of a Clinical Specialist Team. They will use a meta-algorithm integrated in the interactive imergo® e-health Integrated Care Platform to customise patients’ treatment to their individual needs and preferences and liaise among providers. The platform will also empower patients and informal carers to increase their intrinsic capacities. ESCAPE as a social innovation will decrease disease burden for patients, informal carers and ultimately society and improve their quality of life (QoL), prioritised as the most important treatment outcome by patients, carers, and multimorbidity guidelines. ESCAPE will conduct for the first time a randomised controlled trial embedded in a comprehensive cohort study design to compare BCC and usual care. We will include patients with heart failure, ≥2 medical comorbidities and psychological distress. The primary effectiveness endpoint will be patients’ health-related QoL. Medical outcomes, cost-effectiveness, and several other patient-relevant outcomes will be secondary endpoints. We will apply an active dissemination and exploitation strategy to derive maximum impact from the new pathway for multimorbidity care.
Fields of science
Topic(s)
Call for proposal
H2020-SC1-2020-Two-Stage-RTD
See other projects for this call
Funding Scheme
RIA - Research and Innovation actionCoordinator
5230 Odense M
Denmark
Participants (15)
4180 Soroe
37075 Goettingen
20251 Hamburg
50937 Koeln
04109 Leipzig
2 Dublin
44307 Kaunas
1085 Budapest
40124 Bologna
40126 Bologna
80686 Munchen
1040 Bruxelles
40215 Dusseldorf
581 83 Linkoping
D08H67X Dublin